Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

EXMD504 > 11. MicroRNAs in Cancer > Flashcards

11. MicroRNAs in Cancer Flashcards

(93 cards)

Start Studying
1
Q

what organism was miRNA found in?

A

C. elegans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are lin mutants?
why are they used?

A

lineage defective mutants

diff larval stages have diff fates so can trace development thru Lin mutants and map mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is Lin4?

A

miRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lin4L vs Lin4S

A

Lin4L base pairs with itself to form hairpin

Lin4S has shorter, linear sequence

there must be precursor and mature form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

relationship btwn Lin4 and Lin14, how does it work?

A

Lin4 represses Lin14

Lin4 matches Lin14 sequence at 3’ and 5’ ends –> base pairing contributes to repression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe miRNA across organisms

A

miRNA are conserved across organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how did we find that miRNA are conserved across organisms?

A

Let7 miRNA matches in many organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

are miRNA encoding RNA?

A

no!! don’t encode things

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what do miRNA do?

A

just control genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how have miRNA evolved with mRNA?

A

miRNA and mRNA have co-evolved since the beginning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe Let7 mutants in V cells

A

normally V cells divide finite number of times

Let7 mutants divide continuously and never differentiate like cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why do Let7 mutants in V cells cause continuous division?

A

division of V cell is controlled by Ras

Regions of Let7 match 3’ region of Ras to suppress Ras (dose-response relationship)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe Let7 and Ras in cancer cells vs normal cells

what does this mean about the function of Let7?

A

in cancer cells:
-Let7 is reduced and Ras is increased

in normal cells:
- Let7 is increased and Ras is reduced

therefore, Let7 may have TUMOUR SUPPRESSIVE function –> lose Let7 in tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

where are miRNA usually found in genome?

A

at fragile sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are fragile sites

A

region of genome in tumour cells where chunk of info is lost or amplified

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how do we know that fragile sites are not random?

A

fragile sites contain fusions between oncogenes and promoters, as well as miRNA tumour suppressors/oncogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what do we see at fragile site if miRNA is oncogene?

A

would see region amplified (multiple copies) in tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what do we see at fragile site if miRNA is tumour suppressor?

A

region would be lost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

is miRNA-17-92 oncogene or tumour suppressor?

A

oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

how did they find that miR-17-92 is oncogene?

A

found RNA from amplicon highly expressed in lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what oncogene does miR-17-92 interact with?

A

Myc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe 17-92 in Myc driven cancer

A

17-92 is amplified in Myc-driven cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what happens if you transduced 17-92 in mice with overexpressed Myc?

what can you conclude from this?

A

gives tumour with same profile as Burkitt’s Lymphoma

therefore 17-92 involved in lymphomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

describe survival in mice with:
A. overexpressed Myc
B. overexpressed Myc + 17-92

A

A. overexpressed Myc = survival

B. overexpressed Myc + 17-92 = survival drops quickly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
what does miRNA depend on? why? example with Let7/Ras example with 17-92/Myc
miRNA depends on TARGET because it is just a regulator If you have Let7 but no Ras --> nothing will happen If you have 17-92 but no Myc --> nothing will happen
26
where are miRNA encoded?
in genome
27
what transcribes miRNA ?
miRNA is transcribed by Pol II
28
how many miRNA does 1 miRNA transcript make?
can make 1 or multiple miRNA
29
describe the biogenesis of miRNA (5 steps)
1. primary transcript made by pol II in nucleus 2. pri-miRNA is substrate for DROSHA (RNAse) which makes sequences with overhang --> produces pre-miRNA 3. pre-miRNA exported to cytoplasm to meet DICER (RNAse) which makes 2 strands with overhang 4. pre-miRNA captured by Argonaute which cleaves the 2 strands 5. 1 strand is used as a guide to find mRNA targets with miRISC complex
30
pre-miRNA vs pri-miRNA
pri-miRNA = primary transcript transcribed from genome pre-miRNA = cleaved after DROSHA
31
purpose of argonaute?
normally, the 2 strands cleaved from pre-miRNA would be degraded but argonaute cleaves one of the strand
32
why does the miRISC complex have specific scanning mechanism to find targets?
most contacts btwn miRISC complex and targets are non-prouctive
33
what is GW182?
piggybacks on miRISC to help find targets and enacts silencing
34
how did they crystallize the argonaute structure?
use traces of phenol
35
shape of argonaute
crescent shape with 2 lobes
36
describe the domains in the 2 lobes of argonaute
LOBE 1: mid domain and PIWI domain LOBE 2: PAZ domain and N terminal domain
37
which 3 argonaute domains are well-conserved?
Mid, PIWI, PAZ
38
which argonaute domain is more variable/less conserved?
N-terminal
39
which domain of argonaute binds the 5' end of miRNA?
Mid domain
40
what allows specificity for miRNA and argonaute interaction?
1st nucleotide at 5' end embedded in pocket at mid domain allows specificity
41
which domain of argonaute binds the 3' end of miRNA?
PAZ domain
42
describe the interaction of miRNA with argonaute in terms of domains
5' end at Mid domain 3' end at PAZ domain the rest of miRNA is in the cleft
43
what is the significance of the non-5'/3' parts of miRNA being in the cleft?
since the miRNA is in the cleft, the mRNA is also in the cleft
44
what does the PIWI domain of argonaute resemble?
RNAse H
45
what does the PIWI domain do?
cleaves mRNA when there's an RNA-DNA/RNA-RNA hybrid
46
when does the PIWI domain cleave?
only cleaves when the miRNA is fully base paired with mRNA
47
where does the PIWI domain cleave?
cleaves exactly at the 10th nt
48
why does the argonaute scan mRNA in the cell?
to find complementarity btwn miRNA and mRNA
49
in animals, do miRNA perfectly base pair with mRNA targets? example with Lin4 and Lin14
miRNA INCOMPLETELY base-pair with mRNA Lin4 stops base-pairing with Lin 14 by 10th nt
50
since miRNA and mRNA don't completely base-pair, what does indicate about the argonaute cleavage mechanism?
if the goal was to cleave, the co-evolution of the miRNA and mRNA would favour base-pairing in the middle
51
what did ppl initially think was the mechanism for miRNA-mediated silencing?
the cleavage by argonaute
52
what are the names of the 2 current models for miRNA-mediated silencing
1. Deadenylation, Decapping, and Decay 2. mRNA Translation Repression
53
describe the Deadenylation, Decapping, and Decay model of miRNA-mediated silencing 3 steps
1. CCR-NOT is deadenylation complex that removes polyA tail of mRNA 2. loss of polyA tail stimulates enzymes to remove 5' cap 3. deadenylation AND decapping = mRNA loses stability
54
describe the mRNA translation repression model of miRNA-mediated silencing
RISC shuts down transcription initiation and prevents ribosome assembly
55
why is deadenylation bad for mRNA?
polyA tail is important for initiation bc interacts with 5' end and important for stability of 3' end bc acts as protection
56
why are the 2 current models of miRNA-mediated silencing better than the cleavage/slicing model?
these mechanisms allow for better regulation and control bc they can be tuned --> if you just slice, the activity is fully gone
57
if not for miRNA-mediated silencing, what is the role of the slicing mechanism?
2 miRNA are made but must get rid of 1 so it can base pair with its target
58
what are P bodies?
biological condensates --> segregate from cytoplasm and concentrate specific enzymes may be a storage place for mRNA with polyA tail and cap --> then upon exit, the mRNA becomes deadenylated and decayed
59
what is targetscan?
database with all matching sequences in transcriptome for miRNA-mRNA interactions
60
how are many miRNA's organized?
as cluster/polycistron
61
do the pri-miRNAs have the same functions as the mature miRNA? how do we know?
pri-miRNA may contain info for diff functions than mature miRNA many intermediates are made as pri-miRNA is processed --> last intermediate miRNA-19 is most oncogenic
62
can miRNA profile predict cancer patient survival?
yes
63
in profiling of miRNA, what causes miRNA expression to increase or decrease?
miRNA expression varies with cell fate and state, i.e. depending on nutrients/conditions
64
how can we use miRNA to detect cancer
look at changes in miRNA expression and predict origin of cell if you sequence all miRNA in tumour, can determine where it came from, which subtype of cancer it is, and find NEW subtypes of cancer
65
survival curve with Let7 what does this tell us about using miRNA to predict outcome?
data shows high Let7 has best outcome --> Let7 is tumour suppressor just 1 miRNA can help us predict outcome, even if you didn't know what it does
66
how can we profile miRNA?
with NGS
67
what are heatmaps used for? what is clustering? what does red/blue mean?
heatmaps are used to analyze multiple variations in gene expression and represent increases/decreases clustering = grouping genes based on similarities red = increased expression blue = decreased expression
68
relationship between Myc and p53
Myc oncogene will activate p53
69
in cancer with increased Myc, what happens if 17-92 is removed?
17-92 removal --> pre-B cells will survive bc no self-tolerance and lead to autoimmunity 17-92 cannot activate Myc so p53 is inactive
70
in cancer with increased Myc, what happens if 17-92 is expressed?
17-92 expressed --> B cells will die 17-92 activates Myc so p53 is active
71
comparing 2 patients with Burkitt's Lymphoma, 1 with high 17-92 and 1 with low 17-92, which has worst outcome after treatment?
patient with HIGH 17-92 --> tumour cells won't die
72
what happens to PTEN if 17-92 is lost?
PTEN increases --> increased tumour suppressor activity
73
if you knockdown PTEN, what is the outcome?
very bad bc removing tumour suppressor
74
what is BIM?
Induces apoptosis
75
relationship btwn 17-92 and BIM
17-92 allows promotion of proliferation and growth as an oncogene and REPRESSES BIM
76
in lymphoproliferative disease with high 17-92, what happens with PTEN and BIM?
Both decrease
77
why do tumour cells develop oncogene addiction?
cancer causes the loss of many genes --> can maintain a pathway via synthetic lethality but there is strain in the background --> cells lose flexibility and are less adaptable
78
describe 17-92 oncogene addiction
tumour cell relies on 17-92 to survive with Myc overexpression normal cell would be fine if 17-92 was removed
79
why is the DICER heavily oncogenic?
required for 17-92
80
why is 17-92 a good drug target?
tumour is addicted so will die if removed
81
3 ways for RNA to be used as a drug
1. use siRNA with full base-pairing to target gene to slicing activity 2. can mimic miRNA to replaces tumour suppressor 3. inhibit miRNA with modified oligonucleotide
82
give an example of an miRNA mimic that can replace a tumour suppressor
normally, Let7 tumour suppressor suppresses Ras so if Let7 can be restored in tumour cells, tumour will die
83
describe inhibiting oncogenic miRNA with modified oligonucleotide
oligonucleotide can base pair with miRNA and prevent miRNA function
84
what is the main problem with using RNA as a drug?
delivery
85
2 types of overcoming the issue with RNA drug delivery
1. aerosol helpful for lung cancer 2. lipid nanoparticles
86
why must RNA drugs have chemical modifications?
exogenous RNA is normally not taken up and is seen as foreign by innate immunity --> chemical modifications hide the RNA from innate immune system
87
what can determine whether miRNA will function or not?
depends on whether target site is in 3' UTR
88
describe dynamics of 3' UTR
UTRs change with cell state as miRNA changes with cell state
89
describe relationship btwn 3' UTR and cancer
cancer can avoid control by miRNA due to the dynamics of 3' UTR
90
how does 3' UTR change in proliferating cancer cells?
3' UTR can get shorter due to alternative polyadenylation
91
describe short vs long UTR
long UTR has many miRNA binding sites short UTR has fewer miRNA binding sites
92
how can cancer avoid control by miRNA via UTR?
Cancer can shorten the UTR by alternative polyadenylation in proliferating cells
93
in retinoblastoma what happens if you shut down the 17-92 dicer? is this true in all tumours?
tumour dies in other cases, if you shut down drosha or dicer to lose the miRNA, there is greater proliferation

EXMD504 (12 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions